A.R.T. Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

A.R.T. Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,101	Closed	-$1.74M	–	1875
2019 Q3	$1.74M	Buy	15,101 +6,500	+76%	+$987K	0.09%	323
2019 Q2	$1.48M	Buy	8,601 +5,400	+169%	+$934K	0.08%	317
2019 Q1	$540K	Buy	+3,201	New	+$476K	0.03%	719
2018 Q1	–	Sell	-5,557	Closed	-$733K	–	1864
2017 Q4	$733K	Buy	+5,557	New	+$653K	0.03%	747
2016 Q1	–	Sell	-28,927	Closed	-$2.01M	–	1757
2015 Q4	$2.01M	Buy	28,927 +6,726	+30%	+$548K	0.1%	289
2015 Q3	$2.03M	Buy	+22,201	New	+$2.47M	0.08%	375
2015 Q2	–	Sell	-9,286	Closed	-$846K	–	1805
2015 Q1	$846K	Sell	9,286 -3,665	-28%	-$298K	0.03%	724
2014 Q4	$876K	Sell	12,951 -17,256	-57%	-$1.26M	0.03%	707
2014 Q3	$2.44M	Buy	+30,207	New	+$2.67M	0.11%	253
2014 Q2	–	Sell	-31,548	Closed	-$1.87M	–	1620
2014 Q1	$1.87M	Buy	+31,548	New	+$1.88M	0.1%	287

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

A.R.T. Advisors's GWPH Position: Q4 2019 in Review

A.R.T. Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 15,101 shares — an estimated $1.74M sold.

A.R.T. Advisors first reported a position in GWPH in Q1 2014 and held it in 10 quarters. The position peaked at $2.44M in Q3 2014. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

A.R.T. Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 15,101 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $1.74M.
A.R.T. Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 10 quarters.
A.R.T. Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.44M in Q3 2014.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.